BindingDB logo
myBDB logout

BDBM310626 US10150762, Example 2/11

SMILES: CC(C)N(C)C(=O)c1nc(sc1-c1ccc(c(Cl)c1Cl)C(O)(C(F)(F)F)C(F)(F)F)C(=O)NCC(C)(C)O

InChI Key: InChIKey=VPAAXHQWKPTSME-UHFFFAOYSA-N

Data: 1 IC50  1 Kd

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 310626   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM310626
PNG
(US10150762, Example 2/11)
Show SMILES CC(C)N(C)C(=O)c1nc(sc1-c1ccc(c(Cl)c1Cl)C(O)(C(F)(F)F)C(F)(F)F)C(=O)NCC(C)(C)O
Show InChI InChI=1S/C22H23Cl2F6N3O4S/c1-9(2)33(5)18(35)14-15(38-17(32-14)16(34)31-8-19(3,4)36)10-6-7-11(13(24)12(10)23)20(37,21(25,26)27)22(28,29)30/h6-7,9,36-37H,8H2,1-5H3,(H,31,34)
PDB

Reactome pathway

UniProtKB/TrEMBL

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
Cells used in this assay were transiently co-transfected with three different plasmids, one expressing the GAL4-DNA binding domain (DBD)-RORγt f...


US Patent US10150762 (2018)


BindingDB Entry DOI: 10.7270/Q2H1343R
More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM310626
PNG
(US10150762, Example 2/11)
Show SMILES CC(C)N(C)C(=O)c1nc(sc1-c1ccc(c(Cl)c1Cl)C(O)(C(F)(F)F)C(F)(F)F)C(=O)NCC(C)(C)O
Show InChI InChI=1S/C22H23Cl2F6N3O4S/c1-9(2)33(5)18(35)14-15(38-17(32-14)16(34)31-8-19(3,4)36)10-6-7-11(13(24)12(10)23)20(37,21(25,26)27)22(28,29)30/h6-7,9,36-37H,8H2,1-5H3,(H,31,34)
PDB

Reactome pathway

UniProtKB/TrEMBL

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/a 6.10n/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
Project compounds were arranged in a pre-dosed mother plate (Greiner Bio-one) wherein compounds are serially diluted in 100% DMSO by 1:2 from a high ...


US Patent US10150762 (2018)


BindingDB Entry DOI: 10.7270/Q2H1343R
More data for this
Ligand-Target Pair